A2B Adenosine Receptor Antagonists: Recent Developments

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|5|12|1053-1060

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.5, Iss.12, 2005-12, pp. : 1053-1060

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent developments in the field of A 2A and A 3 adenosine receptor antagonists

By Baraldi P.G.   Tabrizi M.A.   Bovero A.   Avitabile B.   Preti D.   Fruttarolo F.   Romagnoli R.   Varani K.   Borea P.A.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 367-382

Elsevier

Access to resources Recommend Favorite

A2B adenosine receptor antagonists and their potential indications

By Zablocki Jeff   Elzein Elfatih   Kalla Rao  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1347-1357

Informa Healthcare

Access to resources Recommend Favorite

Potent Adenosine A1 and A2A Receptors Antagonists: Recent Developments

By  

Current Medicinal Chemistry, Vol. 13, Iss. 30, 2006-01 ,pp. : 3609-3625

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in the Medicinal Chemistry of NK2 Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 12, 2003-08 ,pp. : 1436-1445

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments with neuropeptide Y receptor antagonists

By Lundberg J.M.   Modin A.   Malmstrom R.E.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 301-304

Elsevier

Access to resources Recommend Favorite